Edwin B. Walker
Robert W Franz Cancer Research Center
Earle A Chiles Research Institute
Providence Portland Medical Center
Portland
USA
Name/email consistency: high
- Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood. Walker, E.B., Miller, W., Haley, D., Floyd, K., Curti, B., Urba, W.J. Clin. Cancer Res. (2009)
- Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization. Walker, E.B., Haley, D., Petrausch, U., Floyd, K., Miller, W., Sanjuan, N., Alvord, G., Fox, B.A., Urba, W.J. Clin. Cancer Res. (2008)
- gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells. Walker, E.B., Haley, D., Miller, W., Floyd, K., Wisner, K.P., Sanjuan, N., Maecker, H., Romero, P., Hu, H.M., Alvord, W.G., Smith, J.W., Fox, B.A., Urba, W.J. Clin. Cancer Res. (2004)